MicroRNA-like off-target transcript regulation by siRNAs is species specific

  1. Julja Burchard1,2,
  2. Aimee L. Jackson1,3,
  3. Vladislav Malkov1,
  4. Rachel H.V. Needham1,
  5. Yejun Tan1,
  6. Steven R. Bartz2,
  7. Hongyue Dai1,
  8. Alan B. Sachs2 and
  9. Peter S. Linsley1,3
  1. 1Rosetta Inpharmatics LLC, Seattle, Washington 98109, USA
  2. 2Sirna Therapeutics, San Francisco, California 94185, USA

Abstract

siRNAs mediate sequence-specific gene silencing in cultured mammalian cells but also silence unintended transcripts. Many siRNA off-target transcripts match the guide-strand “seed region,” similar to the way microRNAs match their target sites. The extent to which this seed-matched, microRNA-like, off-target silencing affects the specificity of therapeutic siRNAs in vivo is currently unknown. Here, we compare microRNA-like off-target regulations in mouse liver in vivo with those seen in cell culture for a series of therapeutic candidate siRNAs targeting Apolipoprotein B (APOB). Each siRNA triggered regulation of consistent microRNA-like off-target transcripts in mouse livers and in cultured mouse liver tumor cells. In contrast, there was only random overlap between microRNA-like off-target transcripts from cultured human and mouse liver tumor cells. Therefore, siRNA therapeutics may trigger microRNA-like silencing of many unintended targets in vivo, and the potential toxicities caused by these off-target gene regulations cannot be accurately assessed in rodent models.

Keywords:

Keywords

Footnotes

  • 3 Present address: Regulus Therapeutics LLC, 1896 Rutherford Road, Carlsbad, CA 92008, USA.

  • Reprint requests to: Peter S. Linsley, Regulus Therapeutics, 1896 Rutherford Road, Carlsbad, CA 92008, USA; e-mail: plinsley{at}regulusrx.com; fax: (760) 268-6868.

  • Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/10.1261/rna.1326809.

    • Received August 22, 2008.
    • Accepted October 29, 2008.
| Table of Contents